RUFY2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.088600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.705200E-01
Normal-vs-Stage2
4.741800E-01
Normal-vs-Stage3
7.970400E-02
Normal-vs-Stage4
8.655600E-01
Stage1-vs-Stage2
7.662200E-01
Stage1-vs-Stage3
2.623000E-01
Stage1-vs-Stage4
5.626800E-01
Stage2-vs-Stage3
2.804800E-01
Stage2-vs-Stage4
2.686800E-01
Stage3-vs-Stage4
1.631010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.120000E-01
Normal-vs-AfricanAmerican
5.681400E-01
Normal-vs-Asian
4.653400E-01
Caucasian-vs-AfricanAmerican
8.180400E-01
Caucasian-vs-Asian
6.336600E-01
AfricanAmerican-vs-Asian
6.411200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.062800E-01
Normal-vs-Female
5.295600E-01
Male-vs-Female
7.620800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.053000E-01
Normal-vs-Age(41-60Yrs)
9.500800E-01
Normal-vs-Age(61-80Yrs)
3.606000E-01
Normal-vs-Age(81-100Yrs)
2.553400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.100600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.878200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.309600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.457800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.974100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.382000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.596600E-01
Normal-vs-Daily Drinker
2.138800E-01
Normal-vs-Weekly Drinker
7.397200E-01
Normal-vs-Occasional Drinker
7.418800E-01
Normal-vs-Social Drinker
8.938600E-01
Non Drinker-vs-Daily Drinker
3.141200E-01
Non Drinker-vs-Weekly Drinker
5.983600E-01
Non Drinker-vs-Occasional Drinker
4.239000E-01
Non Drinker-vs-Social Drinker
3.215800E-01
Daily Drinker-vs-Weekly Drinker
2.108200E-01
Daily Drinker-vs-Occasional Drinker
9.834200E-02
Daily Drinker-vs-Social Drinker
8.871600E-02
Weekly Drinker-vs-Occasional Drinker
8.924600E-01
Weekly Drinker-vs-Social Drinker
7.366200E-01
Occasional Drinker-vs-Social Drinker
7.937000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.347900E-02
Normal-vs-Grade 2
2.937600E-03
Normal-vs-Grade 3
6.298400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.794000E-01
Grade 1-vs-Grade 3
2.481800E-01
Grade 1-vs-Grade 4
2.347900E-02
Grade 2-vs-Grade 3
4.043200E-01
Grade 2-vs-Grade 4
2.937600E-03
Grade 3-vs-Grade 4
6.298400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.596000E-01
Normal-vs-NonDiabetic
5.005400E-01
Diabetic-vs-NonDiabetic
3.353200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.475400E-01
Normal-vs-NoPancreatitis
4.615200E-01
Pancreatitis-vs-NoPancreatitis
6.507800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.049200E-01
Normal-vs-N1
4.557000E-01
N0-vs-N1
4.946000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.150600E-01
Normal-vs-TP53-NonMutant
7.273600E-01
TP53-Mutant-vs-TP53-NonMutant
7.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
